Not quite the Oprah house
December 9, 2010
They may look a little bit
like a crowd of excitable Americans,
but the group above are actually
Sydney-based pharmacists and
pharmacy students .
Yesterday they enjoyed an
exclusive tour of iNova
Pharmaceuticals’ corporate
headquarters, for a rare look into
the development and manufacture
of medicines as they head for local
and overseas pharmacy shelves.
The manufacturing and
laboratory plant tour is accredited
for CPD points by the PSA, with
participants taken on a magical
mystery tour from “formulations
and factory floor, to finished goods
in pharmacy store” for a variety of
solid and liquid dosage forms.
As well as seeing how several
pharmacy only brands such as
DuroTuss, Difflam, CalSup and
Metsal are made, the group were
given an overview of iNova’s world
class quality control systems and its
analytical laboratory where
extensive testing and validation of
products is undertaken.
The tour included an address
from iNova ceo Andrew Howden,
who described the company’s focus
on a “strong pipeline of products
that deliver value for patients and
consumers”.
He said that iNova had a well
balanced product mix, with about
half of its range being prescription
medications and the rest being
non-prescription.
iNova gm Australia/NZ Peter
Mayrick also reiterated the firm’s
strong commitment to pharmacyonly
brands.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Dec 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Dec 10
